Trials / Completed
CompletedNCT03798288
Randomised Controlled Trial for the selfBACK Project
A Decision Support System for Self-management of Low Back Pain - a Randomized Controlled Trial for the selfBACK Project
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 461 (actual)
- Sponsor
- University of Southern Denmark · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The intervention consists of a digital decision support system delivering a weekly plan of suggested activities that the participant can use to self-manage their low back pain (LBP) via an smartphone app.
Detailed description
The selfBACK intervention consists of the selfBACK system, that provides the participants with an individually tailored weekly plan of suggested activities to use in their self-management of low back pain. The selfBACK system constitutes a data-driven decision support system that uses case-based reasoning to capture and reuse participant cases to suggest the most suitable self-management plan for participants. The system is an intelligent system delivering self-management plans tailored to individual participant characteristics. Information about participant characteristics is collected via a (baseline) questionnaire, weekly self-reports via the app on symptom progression etc., and a wristband that detect daily number of steps. The weekly plans are presented in an app to participants. The weekly plan includes three categories of content; 1. information/education 2. recommended daily number of steps 3. recommended strength and flexibility exercises Outcomes are collected as baseline, 6 weeks, 3, 6, 9 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | selfBACK | Participants will use the selfBACK system and app in addition to receiving usual care |
| OTHER | Usual care | Participants will receive usual care |
Timeline
- Start date
- 2019-03-08
- Primary completion
- 2020-05-06
- Completion
- 2020-10-20
- First posted
- 2019-01-09
- Last updated
- 2023-02-17
Locations
2 sites across 2 countries: Denmark, Norway
Source: ClinicalTrials.gov record NCT03798288. Inclusion in this directory is not an endorsement.